# MARGENZA
> **BLA761150** · Biologics License Application · Sponsor: MACROGENICS INC · Approved 2020-12-16
## Drug
- **FDA Application Number:** BLA761150
- **Application type:** Biologics License Application
- **Brand name:** MARGENZA
- **Generic name:** MARGETUXIMAB-CMKB
- **Active ingredients:** MARGETUXIMAB-CMKB
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** MACROGENICS INC
- **Manufacturer:** TerSera Therapeutics LLC
- **First approval:** 2020-12-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761150)
---
*AI Analytics · CC0 1.0*